Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis: As measured using cardiac biomarkers

Texas Heart Institute Journal

Volumn 37, Issue 2, 2010, Pages 161-165

  Minutello, Robert M ^a   Kim, Luke ^a   Aggarwal, Smita ^a   Cuomo, Linda J ^a   Feldman, Dmitriy N ^a   Wong, Chiu S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angioplasty, transluminal, percutaneouscoronary standards statistics numerical data; Linear models; Multivariate analysis; Myocardial infarction mortality physiopathology therapy; Myocardial reperfusion methods; Myocardial revascularization utilization; Practice guidelines as topic standards; Regression analysis; Time factors; Treatment outcome

Indexed keywords

CREATINE KINASE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE NECROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY EFFECT; AGED; AREA UNDER THE CURVE; BLOOD; CONVALESCENCE; ENZYMOLOGY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEART INFARCTION; HEART MUSCLE; MIDDLE AGED; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AREA UNDER CURVE; BIOLOGICAL MARKERS; CREATINE KINASE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; QUALITY INDICATORS, HEALTH CARE; RECOVERY OF FUNCTION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77954911066     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/ AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published erratum appears in J Am Coll Cardiol 2008;51(9):977]. J Am Coll Cardiol 2008; 51(2):210-247.
2. Berger PB, Ellis SG, Holmes DR Jr, Granger CB, Criger DA, Betriu A, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999;100(1):14-20.
3. Brodie BR, Stuckey TD, Muncy DB, Hansen CJ, Wall TC, Pulsipher M, Gupta N. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 2003;145(4):708-715.
4. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 2003;92(7):824-826.
5. Zijlstra F, Patel A, Jones M, Grines CL, Ellis S, Garcia E, et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002;23(7):550-7.
6. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Buonamici P, et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 2002;89(11): 1248-1252.
7. De Luca G, Suryapranata H, Zijlstra F, van't Hof AW, Hoornt-je JC, Gosselink AT, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003;42 (6):991-997.
8. McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006;47(11):2180-6.
9. Brodie BR, Hansen C, Stuckey TD, Richter S, Versteeg DS, Gupta N, et al. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol 2006;47(2):289-95.
10. Brodie BR, Stone GW, Cox DA, Stuckey TD, Turco M, Tcheng JE, et al. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myo-cardial infarction: analysis from the CADILLAC trial. Am Heart J 2006;151(6):1231-1238.
11. Nallamothu B, Fox KA, Kennelly BM, Van de Werf F, Gore JM, Steg PG, et al. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart 2007;93(12):1552-1555.
12. Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH, Krumholz HM; NRMI Investigators. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005; 111(6):761-767.
13. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004;109(10):1223-5.
14. Nallamothu BK, Antman EM, Bates ER. Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment? Am J Cardiol 2004;94(6):772-4.
15. Nallamothu BK, Wang Y, Magid DJ, McNamara RL, Herrin J, Bradley EH, et al. Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis. Circulation 2006;113(2):222-229.
16. Jneid H, Fonarow GC, Cannon CP, Palacios IF, Kilic T, Moukarbel GV, et al. Impact of time of presentation on the care and outcomes of acute myocardial infarction. Circulation 2008;117(19):2502-9.
17. Magid DJ, Wang Y, Herrin J, McNamara RL, Bradley EH, Curtis JP, et al. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA 2005;294(7):803-812.
18. Turer AT, Mahaffey KW, Gallup D, Weaver WD, Christen-son RH, Every NR, Ohman EM. Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction. Curr Control Trials Cardiovasc Med 2005;6:12.
19. Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mat-tera JA, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006;355(22): 2308-20.
20. Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, et al. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2008; 358(3):231-240.
21. Zahn R, Vogt A, Zeymer U, Gitt AK, Seidl K, Gottwik M, et al. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angio-plasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiolo-gischer Krankenhausarzte. Heart 2005;91(8):1041-1046.
22. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283(22):2941-2947.
23. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006;114(19):2019-2025.
24. Boersma E; Primary Coronary Angioplasty vs. Thromboly-sis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27(7):779-788.
25. Stone GW, Dixon SR, Grines CL, Cox DA, Webb JG, Brodie BR, et al. Predictors of infarct size after primary coronary an-gioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol 2007;100(9): 1370-1375.